APO Research
Talk to an analyst

APO RESEARCH · REPORT

Analgesic Creams

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Analgesic Creams Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchAnalgesic Creams Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Analgesic Creams Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Analgesic Creams Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Analgesic Creams Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Analgesic Creams Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Analgesic Creams market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Analgesic Creams market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Analgesic Creams market include Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Huarun 999, GSK, Topical BioMedics and THE PURE SOURCE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Analgesic Creams market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Analgesic Creams and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Analgesic Creams sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Analgesic Creams market size, projected growth trends, production technologies, key applications, and end-use industries.

Analgesic Creams Segment by Company

Sanofi

Johnson & Johnson

Novartis

Mylan

Lingrui

Huarun 999

GSK

Topical BioMedics

THE PURE SOURCE

Teikoku Seiyaku

Qizheng

Mercury Healthcare

Hisamitsu

Endo

Actavis

Analgesic Creams Segment by Type

OTC

RX

Analgesic Creams Segment by Application

Muscle Pain

Arthritis Pain

Analgesic Creams Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Analgesic Creams status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Analgesic Creams market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Analgesic Creams significant trends, drivers, influence factors in global and regions.

6. To analyze Analgesic Creams competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic Creams market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Analgesic Creams and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic Creams.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Analgesic Creams market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Analgesic Creams industry.

Chapter 3: Detailed analysis of Analgesic Creams manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Analgesic Creams in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Analgesic Creams in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Analgesic Creams Industry Trends Table 2. Analgesic Creams Industry Drivers Table 3. Analgesic Creams Industry Opportunities and Challenges Table 4. Analgesic Creams Industry Restraints Table 5. Global Analgesic Creams Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Analgesic Creams Revenue Share by Company (2021-2026) Table 7. Global Analgesic Creams Sales Volume by Company (k units) & (2021-2026) Table 8. Global Analgesic Creams Sales Volume Share by Company (2021-2026) Table 9. Global Analgesic Creams Average Price (US$/unit) of Company (2021-2026) Table 10. Global Analgesic Creams Company Ranking, (2024-2026) & (USD Million) Table 11. Global Analgesic Creams Key Company Manufacturing Base & Headquarters Table 12. Global Analgesic Creams Company, Product Type & Application Table 13. Global Analgesic Creams Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Analgesic Creams by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of OTC Table 18. Significant Companies of RX Table 19. Global Analgesic Creams Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Analgesic Creams Sales Volume by Type (2021-2026) & (k units) Table 21. Global Analgesic Creams Sales Volume by Type (2027-2032) & (k units) Table 22. Global Analgesic Creams Sales Volume Share by Type (2021-2026) Table 23. Global Analgesic Creams Sales Volume Share by Type (2027-2032) Table 24. Global Analgesic Creams Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Analgesic Creams Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Analgesic Creams Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Analgesic Creams Sales Value Share by Type (2021-2026) Table 28. Global Analgesic Creams Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Muscle Pain Table 30. Significant Companies of Arthritis Pain Table 31. Global Analgesic Creams Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Analgesic Creams Sales Volume by Application (2021-2026) & (k units) Table 33. Global Analgesic Creams Sales Volume by Application (2027-2032) & (k units) Table 34. Global Analgesic Creams Sales Volume Share by Application (2021-2026) Table 35. Global Analgesic Creams Sales Volume Share by Application (2027-2032) Table 36. Global Analgesic Creams Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Analgesic Creams Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Analgesic Creams Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Analgesic Creams Sales Value Share by Application (2021-2026) Table 40. Global Analgesic Creams Sales Value Share by Application (2027-2032) Table 41. Global Analgesic Creams Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Analgesic Creams Sales by Region (2021-2026) & (k units) Table 43. Global Analgesic Creams Sales Market Share by Region (2021-2026) Table 44. Global Analgesic Creams Sales by Region (2027-2032) & (k units) Table 45. Global Analgesic Creams Sales Market Share by Region (2027-2032) Table 46. Global Analgesic Creams Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Analgesic Creams Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Analgesic Creams Sales Value Share by Region (2021-2026) Table 49. Global Analgesic Creams Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Analgesic Creams Sales Value Share by Region (2027-2032) Table 51. Global Analgesic Creams Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Analgesic Creams Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Analgesic Creams Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Analgesic Creams Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Analgesic Creams Sales by Country (2021-2026) & (k units) Table 56. Global Analgesic Creams Sales Market Share by Country (2021-2026) Table 57. Global Analgesic Creams Sales by Country (2027-2032) & (k units) Table 58. Global Analgesic Creams Sales Market Share by Country (2027-2032) Table 59. Global Analgesic Creams Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Analgesic Creams Sales Value Market Share by Country (2021-2026) Table 61. Global Analgesic Creams Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Analgesic Creams Sales Value Market Share by Country (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sanofi Analgesic Creams Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Analgesic Creams Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Novartis Analgesic Creams Product Portfolio Table 77. Novartis Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Mylan Analgesic Creams Product Portfolio Table 82. Mylan Recent Development Table 83. Lingrui Company Information Table 84. Lingrui Business Overview Table 85. Lingrui Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Lingrui Analgesic Creams Product Portfolio Table 87. Lingrui Recent Development Table 88. Huarun 999 Company Information Table 89. Huarun 999 Business Overview Table 90. Huarun 999 Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Huarun 999 Analgesic Creams Product Portfolio Table 92. Huarun 999 Recent Development Table 93. GSK Company Information Table 94. GSK Business Overview Table 95. GSK Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. GSK Analgesic Creams Product Portfolio Table 97. GSK Recent Development Table 98. Topical BioMedics Company Information Table 99. Topical BioMedics Business Overview Table 100. Topical BioMedics Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Topical BioMedics Analgesic Creams Product Portfolio Table 102. Topical BioMedics Recent Development Table 103. THE PURE SOURCE Company Information Table 104. THE PURE SOURCE Business Overview Table 105. THE PURE SOURCE Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. THE PURE SOURCE Analgesic Creams Product Portfolio Table 107. THE PURE SOURCE Recent Development Table 108. Teikoku Seiyaku Company Information Table 109. Teikoku Seiyaku Business Overview Table 110. Teikoku Seiyaku Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Teikoku Seiyaku Analgesic Creams Product Portfolio Table 112. Teikoku Seiyaku Recent Development Table 113. Qizheng Company Information Table 114. Qizheng Business Overview Table 115. Qizheng Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Qizheng Analgesic Creams Product Portfolio Table 117. Qizheng Recent Development Table 118. Mercury Healthcare Company Information Table 119. Mercury Healthcare Business Overview Table 120. Mercury Healthcare Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Mercury Healthcare Analgesic Creams Product Portfolio Table 122. Mercury Healthcare Recent Development Table 123. Hisamitsu Company Information Table 124. Hisamitsu Business Overview Table 125. Hisamitsu Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Hisamitsu Analgesic Creams Product Portfolio Table 127. Hisamitsu Recent Development Table 128. Endo Company Information Table 129. Endo Business Overview Table 130. Endo Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Endo Analgesic Creams Product Portfolio Table 132. Endo Recent Development Table 133. Actavis Company Information Table 134. Actavis Business Overview Table 135. Actavis Analgesic Creams Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Actavis Analgesic Creams Product Portfolio Table 137. Actavis Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Analgesic Creams Distributors List Table 141. Analgesic Creams Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Analgesic Creams Product Image Figure 2. Global Analgesic Creams Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Analgesic Creams Sales Value (2021-2032) & (US$ Million) Figure 4. Global Analgesic Creams Sales (2021-2032) & (k units) Figure 5. Global Analgesic Creams Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Analgesic Creams Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. OTC Image Figure 10. RX Image Figure 11. Global Analgesic Creams Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Analgesic Creams Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Analgesic Creams Sales Volume Share by Type (2021-2032) Figure 14. Global Analgesic Creams Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Analgesic Creams Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Analgesic Creams Sales Value Share by Type (2021-2032) Figure 17. Muscle Pain Image Figure 18. Arthritis Pain Image Figure 19. Global Analgesic Creams Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Analgesic Creams Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Analgesic Creams Sales Volume Share by Application (2021-2032) Figure 22. Global Analgesic Creams Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Analgesic Creams Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Analgesic Creams Sales Value Share by Application (2021-2032) Figure 25. Global Analgesic Creams Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Analgesic Creams Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Analgesic Creams Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Analgesic Creams Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Analgesic Creams Sales Value (2021-2032) & (US$ Million) Figure 30. North America Analgesic Creams Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Analgesic Creams Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Analgesic Creams Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Analgesic Creams Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Analgesic Creams Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Analgesic Creams Sales Value (2021-2032) & (US$ Million) Figure 36. South America Analgesic Creams Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Analgesic Creams Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Analgesic Creams Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Analgesic Creams Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Analgesic Creams Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Analgesic Creams Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Analgesic Creams Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Analgesic Creams Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • RX
Applications
  • Muscle Pain
  • Arthritis Pain
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Lingrui
  • Huarun 999
  • GSK
  • Topical BioMedics
  • THE PURE SOURCE
  • Teikoku Seiyaku
  • Qizheng
  • Mercury Healthcare
  • Hisamitsu
  • Endo
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Analgesic Creams Sales Value (2021-2032)
  4. 1.2.2 Global Analgesic Creams Sales Volume (2021-2032)
  5. 1.2.3 Global Analgesic Creams Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Analgesic Creams Market Dynamics
  1. 2.1 Analgesic Creams Industry Trends
  2. 2.2 Analgesic Creams Industry Drivers
  3. 2.3 Analgesic Creams Industry Opportunities and Challenges
  4. 2.4 Analgesic Creams Industry Restraints
3 Analgesic Creams Market by Company
  1. 3.1 Global Analgesic Creams Company Revenue Ranking in 2025
  2. 3.2 Global Analgesic Creams Revenue by Company (2021-2026)
  3. 3.3 Global Analgesic Creams Sales Volume by Company (2021-2026)
  4. 3.4 Global Analgesic Creams Average Price by Company (2021-2026)
  5. 3.5 Global Analgesic Creams Company Ranking (2024-2026)
  6. 3.6 Global Analgesic Creams Company Manufacturing Base and Headquarters
  7. 3.7 Global Analgesic Creams Company Product Type and Application
  8. 3.8 Global Analgesic Creams Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Analgesic Creams Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Analgesic Creams Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Analgesic Creams Market by Type
  1. 4.1 Analgesic Creams Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 RX
  4. 4.2 Global Analgesic Creams Sales Volume by Type
  5. 4.2.1 Global Analgesic Creams Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Analgesic Creams Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Analgesic Creams Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Analgesic Creams Sales Value by Type
  9. 4.3.1 Global Analgesic Creams Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Analgesic Creams Sales Value by Type (2021-2032)
  11. 4.3.3 Global Analgesic Creams Sales Value Share by Type (2021-2032)
5 Analgesic Creams Market by Application
  1. 5.1 Analgesic Creams Application Introduction
  2. 5.1.1 Muscle Pain
  3. 5.1.2 Arthritis Pain
  4. 5.2 Global Analgesic Creams Sales Volume by Application
  5. 5.2.1 Global Analgesic Creams Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Analgesic Creams Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Analgesic Creams Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Analgesic Creams Sales Value by Application
  9. 5.3.1 Global Analgesic Creams Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Analgesic Creams Sales Value by Application (2021-2032)
  11. 5.3.3 Global Analgesic Creams Sales Value Share by Application (2021-2032)
6 Analgesic Creams Regional Sales and Value Analysis
  1. 6.1 Global Analgesic Creams Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Analgesic Creams Sales by Region (2021-2032)
  3. 6.2.1 Global Analgesic Creams Sales by Region: 2021-2026
  4. 6.2.2 Global Analgesic Creams Sales by Region (2027-2032)
  5. 6.3 Global Analgesic Creams Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Analgesic Creams Sales Value by Region (2021-2032)
  7. 6.4.1 Global Analgesic Creams Sales Value by Region: 2021-2026
  8. 6.4.2 Global Analgesic Creams Sales Value by Region (2027-2032)
  9. 6.5 Global Analgesic Creams Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Analgesic Creams Sales Value (2021-2032)
  12. 6.6.2 North America Analgesic Creams Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Analgesic Creams Sales Value (2021-2032)
  15. 6.7.2 Europe Analgesic Creams Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Analgesic Creams Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Analgesic Creams Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Analgesic Creams Sales Value (2021-2032)
  21. 6.9.2 South America Analgesic Creams Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Analgesic Creams Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Analgesic Creams Sales Value Share by Country, 2025 VS 2032
7 Analgesic Creams Country-level Sales and Value Analysis
  1. 7.1 Global Analgesic Creams Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Analgesic Creams Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Analgesic Creams Sales by Country (2021-2032)
  4. 7.3.1 Global Analgesic Creams Sales by Country (2021-2026)
  5. 7.3.2 Global Analgesic Creams Sales by Country (2027-2032)
  6. 7.4 Global Analgesic Creams Sales Value by Country (2021-2032)
  7. 7.4.1 Global Analgesic Creams Sales Value by Country (2021-2026)
  8. 7.4.2 Global Analgesic Creams Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Analgesic Creams Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Analgesic Creams Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Analgesic Creams Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Analgesic Creams Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Analgesic Creams Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Analgesic Creams Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Analgesic Creams Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Analgesic Creams Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Analgesic Creams Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Analgesic Creams Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Analgesic Creams Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Analgesic Creams Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Analgesic Creams Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Analgesic Creams Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Analgesic Creams Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Analgesic Creams Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Analgesic Creams Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Analgesic Creams Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Analgesic Creams Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Analgesic Creams Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Analgesic Creams Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Analgesic Creams Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Analgesic Creams Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Analgesic Creams Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Analgesic Creams Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Analgesic Creams Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Analgesic Creams Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Analgesic Creams Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Analgesic Creams Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Analgesic Creams Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Analgesic Creams Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Analgesic Creams Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Analgesic Creams Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Analgesic Creams Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Analgesic Creams Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Lingrui
  26. 8.5.1 Lingrui Company Information
  27. 8.5.2 Lingrui Business Overview
  28. 8.5.3 Lingrui Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lingrui Analgesic Creams Product Portfolio
  30. 8.5.5 Lingrui Recent Developments
  31. 8.6 Huarun 999
  32. 8.6.1 Huarun 999 Company Information
  33. 8.6.2 Huarun 999 Business Overview
  34. 8.6.3 Huarun 999 Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Huarun 999 Analgesic Creams Product Portfolio
  36. 8.6.5 Huarun 999 Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GSK Analgesic Creams Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Topical BioMedics
  44. 8.8.1 Topical BioMedics Company Information
  45. 8.8.2 Topical BioMedics Business Overview
  46. 8.8.3 Topical BioMedics Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Topical BioMedics Analgesic Creams Product Portfolio
  48. 8.8.5 Topical BioMedics Recent Developments
  49. 8.9 THE PURE SOURCE
  50. 8.9.1 THE PURE SOURCE Company Information
  51. 8.9.2 THE PURE SOURCE Business Overview
  52. 8.9.3 THE PURE SOURCE Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 THE PURE SOURCE Analgesic Creams Product Portfolio
  54. 8.9.5 THE PURE SOURCE Recent Developments
  55. 8.10 Teikoku Seiyaku
  56. 8.10.1 Teikoku Seiyaku Company Information
  57. 8.10.2 Teikoku Seiyaku Business Overview
  58. 8.10.3 Teikoku Seiyaku Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Teikoku Seiyaku Analgesic Creams Product Portfolio
  60. 8.10.5 Teikoku Seiyaku Recent Developments
  61. 8.11 Qizheng
  62. 8.11.1 Qizheng Company Information
  63. 8.11.2 Qizheng Business Overview
  64. 8.11.3 Qizheng Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Qizheng Analgesic Creams Product Portfolio
  66. 8.11.5 Qizheng Recent Developments
  67. 8.12 Mercury Healthcare
  68. 8.12.1 Mercury Healthcare Company Information
  69. 8.12.2 Mercury Healthcare Business Overview
  70. 8.12.3 Mercury Healthcare Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Mercury Healthcare Analgesic Creams Product Portfolio
  72. 8.12.5 Mercury Healthcare Recent Developments
  73. 8.13 Hisamitsu
  74. 8.13.1 Hisamitsu Company Information
  75. 8.13.2 Hisamitsu Business Overview
  76. 8.13.3 Hisamitsu Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Analgesic Creams Product Portfolio
  78. 8.13.5 Hisamitsu Recent Developments
  79. 8.14 Endo
  80. 8.14.1 Endo Company Information
  81. 8.14.2 Endo Business Overview
  82. 8.14.3 Endo Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Endo Analgesic Creams Product Portfolio
  84. 8.14.5 Endo Recent Developments
  85. 8.15 Actavis
  86. 8.15.1 Actavis Company Information
  87. 8.15.2 Actavis Business Overview
  88. 8.15.3 Actavis Analgesic Creams Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Actavis Analgesic Creams Product Portfolio
  90. 8.15.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Analgesic Creams Value Chain Analysis
  2. 9.1.1 Analgesic Creams Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Analgesic Creams Sales Mode & Process
  6. 9.2 Analgesic Creams Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Analgesic Creams Distributors
  9. 9.2.3 Analgesic Creams Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst